Intrinsic Therapeutics
Intrinsic Therapeutics is a medical device company focused on delivering a safe treatment to improve efficacy in patients who are at a disproportionately high risk of requiring repeat surgeries due to reherniation following a lumbar discectomy surgery. The Barricaid bone-anchored annular closure device received FDA PMA-approval following completion of a 554-patient randomized controlled trial that achieved superiority at two years. Survival analyses have indicated statistical significance in reducing reherniations and reoperations through five years. See http://www.barricaid.com for complete benefit-risk information.
Last updated on
About Intrinsic Therapeutics
Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$114MCategory
Location
City
WoburnState
MassachusettsCountry
United StatesTech Stack (103)
Devops And Development
Customer Management
Business Intelligence And Analytics
IT Security
Platform And Storage
Collaboration
Product And Design
Computer Networks
Finance And Accounting
Health Tech
IT Management
Analytics and Tracking
Widgets
Gravity Forms
Hubspot Messages
HubSpot WordPress Plugin
Fontello
HubSpot Conversations
WP Rocket
CookieYes
ShareThis
Yoast Plugins
Sitelinks Search Box
Wordpress Plugins
Google Font API
Google Tag Manager
Font Awesome
reCAPTCHA
Image Hotspot by DevVN
Elementor
US Privacy User Signal Mechanism
CrUX Dataset
Gravatar Profiles
Global Privacy Control
YouTube IFrame Upload